top of page

On June 3 and 4, 2024, the Immunotherapy Laboratory (LAIT) has the honor of promoting the 1st National Immunotherapy Symposium.


This event will bring together renowned researchers and professionals in the field, presenting and discussing the most recent advances in immunotherapy and the study of the tumor microenvironment.


Lectures will cover a wide range of topics, including CAR-T development, mRNA-based immunotherapies, resident macrophages, monoclonal antibody engineering, multiomics analysis, and studies on immunotherapy and vaccines for glioblastoma.


Additionally, participants will have the opportunity to attend work presentations, poster exhibitions and participate in exclusive networking sessions.


Prepare for a deep dive into the cutting edge of immunotherapeutic science. Spaces are limited, so make sure you register!

Schedule

Monday, June 3, 2024
12:00-14:00 - Reception and placement of posters
14:00-14:15 - Welcome (Cristina Bonorino)
14:15-15:45 - Designing Immunotherapies in Brazil

  • Martin Bonamino – INCA - “CAR-T cell developments at INCA”

  • Patricia Neves - Fiocruz RJ - "Immunotherapies based on mRNA"

  • Cristina Bonorino - UFCSPA - “Engineering monoclonal antibodies and other molecules for therapy”

15:45-16:15 - Short talks from selected posters
16:15-16:30 - Break
16:30-18:00 - Tumor Microenvironment I

  • Larissa Cunha - USP - UFMRP - “Pathways to tune the responses of macrophages in the tumor microenvironment.”

  • Mariana Boroni – INCA - “Characterization of Myeloid-Derived Cells and Their Clinical Relevance in Cancer”

  • Tiago Medina – AC Camargo - “Spotlighting tertiary lymphoid structures in PDACs”

18:00-19:40 - Visit to the posters and Coffee Break (provided)

19:40-20:00 - Closing

Tuesday, June 4, 2024

8:00 - 08:10 - Reception and placement of posters

08:10 - 08:30 - Welcome (Cristina Bonorino)

08:30 - 10:30 - Tumor Microenvironment II

  • Rodrigo Nalio - IDOR and FMUSP - “Tissue-resident Macrophages as immune-thermometers for the tumor onset”

  • Luiz Rodrigues - UFCSPA - “Resident memory T cells as targets for immunotherapy”

  • Adriana Bonomo - UFRJ - “T cells in metastasis: friends or foes?”

10:30 - 11:00 - Break
11:00 - 12:00 - Response versus resistance to immunotherapy

  • Kenneth Gollob - Enstein - “Multiomics approaches towards discovery of novel immunotherapy targets and identification of clinically actionable biomarkers in cancer.”

  • Kelly Magalhães - UnB - “The obesity paradox impact in cancer immunotherapy”

12:00 - 13:00 - Molecular Bases for Immunotherapy

  • Saigopalakrishna Yerneni - Univ Pittsburgh - “Enabling next generation gene therapies”

  • João Viola - INCA - “Molecular regulation of T cell exhaustion”

13:00 - 14:00 - Break for lunch (not provided)
14:00 - 15:30 - Immunotherapy for Glioblastoma

  • Elizandra Braganhol – UFCSPA - “CD73-based immunotherapy for glioblastoma: from the bench to the patient”

  • José Alexandre Barbuto - USP - “Dendritic cell vaccines in glioblastoma”

  • Juliana Azambuja - Univ Pittsburgh - “Harnessing tumor associated macrophages in glioblastoma”

15:30 - 16:00 - Short talks from selected posters
16:30 - 17:00 - Visit to the posters and Coffee Break (provided)
17:30 - 18:00 - Directions for the creation of a National Immunotherapy Society
18:00 - Closing

LOGOTIPO SIMPÓSIO NAC IMUNOTERAPIA.png

Deadline for Abstracts submission: April, 20

Result of selected works: April, 27

Send abstracts to:

lab.imunoterapia@gmail.com
or 
millenas@ufcspa.edu.br

  • References should be restricted to a minimum (no author names) and, if necessary, the abbreviated journal title should be used, followed by volume: first page-last page, year (e.g. Brain Res. 472:24-40, 1992). Citations like (Ashley et al., 1994) will not be accepted.

  • Abstracts should not exceed Two thousand (2,000) characteres including spaces.

  • Abstract titles should not exceed 255 characters, including spaces.

  • The names, e-mails, CPF (only Brazilians) and Passport number and affiliations of all authors should be included in the abstract submission form.

  • Abbreviations should be defined when they are first mentioned in the abstract.

  • Abstracts should not contain tables, graphs, or images.

  • The poster must contain the authors’ title, name and affiliation;

  • The title of the poster must be the same as the accepted abstract;

  • Measure: 0.90m x 1.20m (width x height) with string for hanging;

  • They should include: introduction, objectives, methodology, results and conclusions.

  • Presentation of the poster for selected abstract are MANDATORY.

As a reminder, all accepted abstracts must be accompanied by a poster presentation. The poster must be presented by the participant who submitted the abstract (PRESENTER) at the time and place determined by the organization.


All poster presentations will be evaluated by independent evaluators, based on the following criteria:

  • Relevance

  • Originality and innovation

  • Clarity of presentation

  • Quality of research

  • Conclusions and implications for the field

  • The best posters will receive an honorable mention certificate (referred to as ‘Poster of Distinction’). The decisions of the evaluators will be final, and the certificates will be distributed at the closing ceremony.

  • We wish you the best of luck with your poster presentation and look forward to your participation at our event. Please feel free to contact us if you have any questions.

LOGOTIPO SIMPÓSIO NAC IMUNOTERAPIA.png

@laitimuno

We are trying to improve your experience!

If you have any questions, contact our social networks (@laitimuno) or email the official organizers (millenas@ufcspa.edu.br).
We will respond as soon as possible.

bottom of page